Interesting that MJFF is presenting a web seminar Thursday regarding" More Peaks, Fewer Valleys with Levodopa". We all know the effectiveness of Eltoprazine in helping to moderate Levodopa, as does MJFF.
"Dyskinesia is a top priority for the Foundation because of its impact on the quality of life of people living with Parkinson’s disease,”

“The results show early promise in finding a potential treatment for dyskinesia, and we look forward to working with this team to drive their program forward.”

Todd Sherer, PhD, CEO of The Michael J. Fox Foundation. courtesy of Natural Treasures over on IHUB.
Timing is interesting that this web seminar is this Thursday. I will be surprised if there is not mention of Eltoprazine. If there is, it will just add to the current momentum. Gerald is keenly aware of the status of AMBS pps right now and has vocally on numerous occasions voiced the intention to uplist to a national exchange this year. I don't believe he is going to allow this current uptrend to falter. As I have stated before, this week I do believe we are going to get some substantive news! Gerald, continues to deliver, and we may close Friday at a new HOY! Sleep well AMBS comrades!